The Lombardi researchers , a number of anti-estrogen-sensitive and antiestrogen – resistant human breast cells studied using a variety of different microarray technologies. ‘The logical implication of our work is that by adding the protein interferon anti-estrogen therapy, we should be able to turn on the IRF-1 these these tumors sensitive to antiestrogen therapy, hopefully inhibiting new breast cancers or reoccurrences disease, ‘said disease, ‘said Clarke.

The study, which shows by Robert Clarke, professor of oncology, Led, there is a link between the gene IRF 1 and breast tumor resistance to tamoxifen or other antiestrogen treatment be. IRF-1 is a tumor suppressor previously associated previously associated with breast cancer.Kiang Forschungs – Gruppe IST spezialisiert auf Form Untersuchung In der Physikalischen und mechanischen EIGENSCHAFTEN v.

Other articles from category "doctor":

Random articles